MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-17-2025
Zynex Total Assets 2011-2026 | ZYXI
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122 M | 137 M | 116 M | 133 M | 72.2 M | 28.3 M | 16.2 M | 8.93 M | 4.09 M | 3.7 M | 7.11 M | 17.2 M | 25.9 M | 21.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 137 M | 3.7 M | 51 M |
Quarterly Total Assets Zynex
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.3 M | 85.9 M | 106 M | 122 M | 126 M | 122 M | 126 M | 137 M | 151 M | 153 M | 111 M | 116 M | 115 M | - | 132 M | 133 M | 90.7 M | 83.7 M | 70.2 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 28.3 M | 28.3 M | 28.3 M | 28.3 M | 19.3 M | 19.3 M | 19.3 M | 19.3 M | 8.93 M | 8.93 M | 8.93 M | 8.93 M | 4.09 M | 4.09 M | 4.09 M | 4.09 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 7.11 M | 7.11 M | 7.11 M | 7.11 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 153 M | 3.7 M | 49.3 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
7.36 M | $ 2.22 | 5.21 % | $ 3.47 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 10.55 | 1.25 % | $ 1.43 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
498 M | $ 8.37 | -0.18 % | $ 601 M |  Israel |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.25 | 8.7 % | $ 900 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 12.96 | 2.82 % | $ 1.94 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.07 | 2.73 % | $ 152 M |  France |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 71.21 | 2.03 % | $ 105 B | USA |
 |
Establishment Labs Holdings
ESTA
|
357 M | $ 65.47 | 3.13 % | $ 1.94 B |  Costa-rica |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 37.07 | -0.91 % | $ 1.15 B | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.69 | 6.15 % | $ 37.6 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
39.2 M | $ 11.2 | 1.54 % | $ 303 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
199 M | $ 18.43 | 0.05 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.24 | 2.43 % | $ 1.36 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
766 M | $ 13.57 | 1.01 % | $ 877 M | Israel |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 62.78 | 2.2 % | $ 3.42 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
86.7 B | $ 111.63 | 1.53 % | $ 194 B | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 4.39 | -0.34 % | $ 649 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.87 | 0.61 % | $ 354 M | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 269.13 | 3.02 % | $ 7.59 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
210 M | $ 2.59 | - | $ 152 M | Israel |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.17 | 1.78 % | $ 706 M | USA |
 |
AxoGen
AXGN
|
222 M | $ 33.1 | 0.79 % | $ 1.52 B | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 178.63 | 5.42 % | $ 13.4 B | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 33.89 | 3.43 % | $ 5.05 K | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
66.8 M | $ 3.75 | 2.18 % | $ 154 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 17.29 | 1.05 % | $ 406 M | USA |